News

: StealthEnomics; Curriculum Development; 01 August 2016; Hits: 642; Rating:

Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 9-7-2018

Funding Opportunity : PA-16-075

CFDA : 93.279|000000

Agency : Department of Health and Human Services

Contact : NIH OER Webmaster
This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Eligibility : State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Native American Tribal Governments (Federally recognized)
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Nonprofits Having a 501 (c) (3) Status with the IRS (other than institutions of higher education)
Nonprofits that do not have a 501 (c) (3) status with the IRS (other than institutions of higher education)
Private institutions of higher education
For-profit organizations other than small business
Small businesses
Others

Details :
This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R21) applications from institutions/ organizations that propose to develop non-invasive methods to support outpatient clinical trials of pharmacotherapies for Substance Use Disorders (SUDs).

Tags: Health, Education

: StealthEnomics; Curriculum Development; 01 August 2016; Hits: 636; Rating:

Behavioral and Integrative Treatment Development Program (R01)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 1-7-2019

Funding Opportunity : PA-16-072

CFDA : 93.273|93.279|000000

Agency : Department of Health and Human Services

Details :
The purpose of this FOA is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, optimize combinations, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) drug abuse treatment and adherence interventions for use in primary care; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat chronic pain. Research of interest includes but is not limited to Stage II and Stage III efficacy research.

Tags: Health, Education

: StealthEnomics; Curriculum Development; 01 August 2016; Hits: 668; Rating:

Behavioral and Integrative Treatment Development Program (R03)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 1-7-2019

Funding Opportunity : PA-16-074

CFDA : 93.273|93.279|000000

Agency : Department of Health and Human Services

Details :
The purpose of this FOA is to encourage investigators to propose discrete well-defined projects that can be completed within two years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) substance abuse; (b) prevention of acquisition or transmission of HIV infection among individuals in drug abuse treatment; (c) promotion of adherence to drug abuse treatment, HIV and addiction medications; and (d) chronic pain. Specific examples include, but are not limited to studies focusing on: 1) Stage I intervention generation; 2) Stage I pilot or feasibility and both should include the development of putative moderators, mediators, and change mechanisms; (3) Stage I studies to generate or refine drug abuse treatment or adherence interventions; (4) Stage I research to boost effects and increase implementability of interventions with creative use of technology or through other means.

Tags: Health, Education

: StealthEnomics; Curriculum Development; 01 August 2016; Hits: 616; Rating:

Behavioral and Integrative Treatment Development Program (R34)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 1-7-2019

Funding Opportunity : PA-16-073

CFDA : 93.273|93.279|000000

Agency : Department of Health and Human Services

Details :
The purpose of this FOA is to encourage investigators to propose discrete well-defined projects that can be completed within three years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) substance abuse; (b) prevention of acquisition or transmission of HIV infection among individuals in substance abuse treatment; (c) promotion of adherence to substance abuse treatment, HIV and addiction medications; and (d) chronic pain. Specific examples include, but are not limited to studies focusing on: 1) Stage I intervention generation; 2) Stage I pilot or feasibility and both should include the development of putative targets/ moderators, mediators, and change mechanisms;(3) Stage I studies to generate or refine substance abuse treatment or adherence interventions for use in primary care; (4) Stage I research to boost effects and increase implementability of interventions with creative use of technology or other means.

Tags: Health, Education

: StealthEnomics; Curriculum Development; 01 August 2016; Hits: 647; Rating:

Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01)

User Rating: 0 / 5

Programming Grants to Accompany NEH on the Road Exhibitions

Deadline : 9-7-2018

Funding Opportunity : PA-16-076

CFDA : 93.279|000000

Agency : Department of Health and Human Services

Details :
This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R01) applications from institutions/ organizations that propose to develop non-invasive methods to support outpatient clinical trials of pharmacotherapies for Substance Use Disorders (SUDs).

Tags: Health, Education

Message

Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)

Programming Grants to Accompany NEH on the Road Exhibitions

Behavioral and Integrative Treatment Development Program (R01)

Programming Grants to Accompany NEH on the Road Exhibitions

Behavioral and Integrative Treatment Development Program (R03)

Programming Grants to Accompany NEH on the Road Exhibitions

Behavioral and Integrative Treatment Development Program (R34)

Programming Grants to Accompany NEH on the Road Exhibitions

Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01)

Programming Grants to Accompany NEH on the Road Exhibitions

Grant Deadline Feeds

Search